Shasqi
Shasqi is seeking an experienced Principal Scientist to lead ADME/PK strategy and execution for its next‑generation tumor‑targeting platform. The role involves designing and interpreting preclinical PK, biodistribution, and translational modeling studies, collaborating cross‑functionally, and shaping IND‑enabling and first‑in‑human strategies in a fast‑paced biotech environment.
Shasqi uses click chemistry to target cancer drugs directly to the tumor, minimizing side effects and potentially improving the therapeutic index
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Shasqi.
11% below the average for this role
Scientist/Senior Scientist
ASTARPRD
Senior Principal Scientist, ADME-PK
Dyne Therapeutics
Principal Scientist, ADME-PK
Dyne Therapeutics
Scientific Associate Director - Pharmacokinetics and Drug Metabolism (Small Molecule ADME Lab Lead)
Amgen
Principal Scientist, Drug Metabolism and Pharmacokinetics
alnylam
ADME / DMPK Scientist
Eli Lilly and Company